Remdesivir close to EU's initial authorisation as COVID-19 treatment
Monday, 18 May 2020 The head of the European Union's medicines agency Guido Rasi said on Monday an initial authorisation for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days.
The head of the European Union's medicines agency, Guido Rasi, has said an initial authorization for U.S. pharmaceutical company Gilead's remdesivir as a COVID-19 treatment could be granted in coming days. Joe Davies reports.
The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir. According to Reuters, the agency said the co-administration may result in the reduced effectiveness of remdesivir. Remdesivir is currently the only medication to show benefits against COVID-19 in clinical trials.
Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported making the total toll to 8102. Out of the total number of cases, 1,37,448 are active while 1,41,029 have been cured. In Maharashtra, coronavirus cases reached 94,041 including 46,086 active cases and 3,438 deaths which are highest in the country. Indian Council of Medical Research informed that there is no 'community transmission' of COVID-19 in India. Earlier on June 11, Lav Agarwal, Joint Secretary, Health Ministry, said that India's recovery rate is 49.21 per cent. A total of 52,13,140 samples have been tested in the country, including 1,51,808 in the last 24 hours, according to ICMR. One new case of COVID-19 reported in ITBP in the last 24 hours. Remdesivir, an antiviral drug and Tocilizumab, an immunomodulator, are being considered by the Union Health Ministry for 'restricted, emergency use' and on 'compassionate grounds' to treat severely ill COVID-19 patients.
As many as 20 major EU banks are set to announce details for a new payments initiative in the very near future. This announcement came from Electronic Payments International. Business Insider reports the system is referred to as the Pan European Payment System Initiative (PEPSI). It will process card payments in addition to making fund transfers and mobile payments without using Mastercard's or Visa's network.
The UK left the European Union on January 31. Here we look at the latest figures and key dates in the ongoing Brexit process. Quote from Sarah Hewin, Chief economist at Standard Chartered, speaking to the Financial Times.
Credit: PA - Press Association STUDIO Duration: 00:48Published
The novel coronavirus COVID-19 pandemic has forced many universities to shift to online-only courses. CNN reports the Department of Immigration and Customs Enforcement has responded swiftly. ICE announced Monday that international students will have to leave the country or risk deportation if their universities only deliver education online. Thousands of foreign students come to the US to attend universities and training programs, as well as non-academic or vocational studies.
As if a global pandemic of the novel coronavirus COVID-19 weren't enough, Gizmodo reports the bubonic plague has reared its nasty head once again. Sunday, officials from Inner Mongolia revealed a shepherd has been diagnosed with bubonic plague, also known as the Black Death. At the same time, a second case has been identified in neighboring Mongolia. Both patients had had contact with a wild marmot, and both are recovering. In the region, subsistence hunting is common.
Hundreds of scientists across the world have a burning question for the World Health Organization. According to Gizmodo, they just petitioned the WHO via an open letter with one demand. The demand is that the WHO acknowledge publicly that the novel coronavirus behind COVID-19 can be airborne. That means it can spread through the air (and linger there) via tiny aerosols emitted by the breath of infected people, not just large droplets. The letter puts the WHO in a tight spot.
Tibetans-in-exile in north Indian celebrated the 85th birthday of their spiritual leader Dalai Lama on July 06. Local Tibetan NGOs, monks and others from Tibetan community gathered on the main mall road of Shimla city to distribute masks and sanitizers among the locals in streets. One of the Buddhist monks said, "Due to COVID-19, we could not have a huge celebration on Dalai Lama's 85th birthday. Tibetans feel proud to celebrate his birthday by distributing sanitizers and masks among the people here." The Dalai Lama assumed full political powers in 1950 after the Chinese invasion of Tibet in 1949. In March 1959 after the suppression of Tibetan National Uprising Dalai Lama was forced to escape into exile in India with over eighty thousand refugees. For the last over six decades Dalai Lama has been working for the promotion of peace, love and compassion.
The European Commission said Friday it had given conditional approval for the use of antiviral drug remdesivir in severe COVID-19 patients. As Fred Katayama reports, that makes it the region's first authorized therapy to treat the virus.
Gilead is the pharmaceutical company behind a drug that’s been approved for COVID emergencies. The FDA officially announced the medicine could be used in treating COVID-19 patients. Gilead has now announced the drug will cost $3,120 per typical treatment course for insured individuals. Research has indicated the drug could cut the recovery time for hospitalized COVID-19 patients. It could shorten satsy by several days, reports Gizmodo.
U.S. stocks posted gains Monday as signs of U.S. economic recovery helped offset jitters over increasingly violent social unrest amid an ongoing pandemic and rising U.S.-China tensions. Fred Katayama reports.